62 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
and equipment, net
Operating right-of-use assets
Restricted cash and cash equivalents, noncurrent
Long-term investments
Other assets
TOTAL ASSETS
LIABILITIES …
Deferred revenue, noncurrent
Operating lease liabilities, noncurrent
Contingent consideration, noncurrent
Other long-term liabilities
TOTAL LIABILITIES
8-K
EX-99.1
VIR
Vir Biotechnology Inc
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
cash and cash equivalents, noncurrent
Long-term investments
Other assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES … , noncurrent
Contingent consideration, noncurrent
Other long-term liabilities
TOTAL LIABILITIES
Commitments and contingencies (Note 7)
STOCKHOLDERS
8-K
EX-99.1
ejuu6d
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
qnmx3qq
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
tam yfnrrrd1
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
458fujsrpqhubo88x
9 Aug 22
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
tbsgecrz
5 May 22
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
m80r86tpnm5okgxbr
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm